US readies (human) vaccine (against bird flu) for testing
submited by kickingbird at Sep, 30, 2004 10:5 AM from Straits Times,燬ingapore
WASHINGTON - As part of planning for a possible bird flu pandemic, the United States´ Department of Health and Human Services has contracted two drug companies to make batches of vaccine, which will be tested in people in late winter or early spring.
The vaccine - to be produced by Aventis Pasteur and Chiron - is a hybrid, comprising a flu strain that is used in standard influenza vaccines and genes taken from a strain of the H5N1 bird flu isolated from a Vietnamese patient last year.
Ultimately, two million doses would be stored for future use.
If a pandemic does break out, the new vaccine would be distributed to protect US laboratory workers and public health personnel. Given the limited stockpile, the government is seeking suggestions as to who else should get the vaccine in the event of an outbreak.
- USCDC: Avian Influenza A(H5N1) U.S. Situation Update and CDC Activities 5 days ago
- USCDC: Urgent field correction notice 6 days ago
- Joint FAO/WHO/WOAH preliminary assessment of recent influenza A(H5N1) viruses 6 days ago
- Primers and probes for H5 and N1 qRT-PCR detection [CNIC] 7 days ago
- USDA: Actions to Protect Livestock Health From Highly Pathogenic H5N1 Avian Influenza 8 days ago
[Go Top] [Close Window]
